#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Pathogen Specific, IRF3-Dependent Signaling and Innate Resistance to Human Kidney Infection


The mucosal immune system identifies and fights invading pathogens, while allowing non-pathogenic organisms to persist. Mechanisms of pathogen/non-pathogen discrimination are poorly understood, as is the contribution of human genetic variation in disease susceptibility. We describe here a new, IRF3-dependent signaling pathway that is critical for distinguishing pathogens from normal flora at the mucosal barrier. Following uropathogenic E. coli infection, Irf3−/− mice showed a pathogen-specific increase in acute mortality, bacterial burden, abscess formation and renal damage compared to wild type mice. TLR4 signaling was initiated after ceramide release from glycosphingolipid receptors, through TRAM, CREB, Fos and Jun phosphorylation and p38 MAPK-dependent mechanisms, resulting in nuclear translocation of IRF3 and activation of IRF3/IFNβ-dependent antibacterial effector mechanisms. This TLR4/IRF3 pathway of pathogen discrimination was activated by ceramide and by P-fimbriated E. coli, which use ceramide-anchored glycosphingolipid receptors. Relevance of this pathway for human disease was supported by polymorphic IRF3 promoter sequences, differing between children with severe, symptomatic kidney infection and children who were asymptomatic bacterial carriers. IRF3 promoter activity was reduced by the disease-associated genotype, consistent with the pathology in Irf3−/− mice. Host susceptibility to common infections like UTI may thus be strongly influenced by single gene modifications affecting the innate immune response.


Vyšlo v časopise: Pathogen Specific, IRF3-Dependent Signaling and Innate Resistance to Human Kidney Infection. PLoS Pathog 6(9): e32767. doi:10.1371/journal.ppat.1001109
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001109

Souhrn

The mucosal immune system identifies and fights invading pathogens, while allowing non-pathogenic organisms to persist. Mechanisms of pathogen/non-pathogen discrimination are poorly understood, as is the contribution of human genetic variation in disease susceptibility. We describe here a new, IRF3-dependent signaling pathway that is critical for distinguishing pathogens from normal flora at the mucosal barrier. Following uropathogenic E. coli infection, Irf3−/− mice showed a pathogen-specific increase in acute mortality, bacterial burden, abscess formation and renal damage compared to wild type mice. TLR4 signaling was initiated after ceramide release from glycosphingolipid receptors, through TRAM, CREB, Fos and Jun phosphorylation and p38 MAPK-dependent mechanisms, resulting in nuclear translocation of IRF3 and activation of IRF3/IFNβ-dependent antibacterial effector mechanisms. This TLR4/IRF3 pathway of pathogen discrimination was activated by ceramide and by P-fimbriated E. coli, which use ceramide-anchored glycosphingolipid receptors. Relevance of this pathway for human disease was supported by polymorphic IRF3 promoter sequences, differing between children with severe, symptomatic kidney infection and children who were asymptomatic bacterial carriers. IRF3 promoter activity was reduced by the disease-associated genotype, consistent with the pathology in Irf3−/− mice. Host susceptibility to common infections like UTI may thus be strongly influenced by single gene modifications affecting the innate immune response.


Zdroje

1. ChotivanichK

UdomsangpetchR

PattanapanyasatK

ChierakulW

SimpsonJ

2002 Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria. Blood 100 1172 1176

2. RagnarsdottirB

FischerH

GodalyG

Gronberg-HernandezJ

GustafssonM

2008 TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. Eur J Clin Invest 38 Suppl 2 12 20

3. SvanborgC

BergstenG

FischerH

GodalyG

GustafssonM

2006 Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol 9 33 39

4. MogensenTH

2009 Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22 240 273, Table of Contents

5. KimHM

ParkBS

KimJI

KimSE

LeeJ

2007 Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130 906 917

6. BellJK

BotosI

HallPR

AskinsJ

ShiloachJ

2005 The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci U S A 102 10976 10980

7. KobeB

KajavaAV

2001 The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 11 725 732

8. FischerH

YamamotoM

AkiraS

BeutlerB

SvanborgC

2006 Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur J Immunol 36 267 277

9. HedlundM

SvenssonM

NilssonA

DuanRD

SvanborgC

1996 Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J Exp Med 183 1037 1044

10. HannunY

BellR

1989 Functions of sphingolipids and sphingolipid break-down products in cellular regulation. Science 247 500 507

11. KolesnickR

1991 Sphingomyelin and derivatives as cellular signals. Prog Lipid Res 30 1 38

12. ZhangY

LiX

BeckerKA

GulbinsE

2009 Ceramide-enriched membrane domains–structure and function. Biochim Biophys Acta 1788 178 183

13. HannunYA

1996 Functions of ceramide in coordinating cellular responses to stress. Science 274 1855 1859

14. HedlundM

NilssonÅ

DuanRD

SvanborgC

1998 Sphingomyelin, glycosphingolipids and ceramide signalling in cells exposed to P fimbriated Escherichia coli. Mol Microbiol 29 1297 1306

15. GrassmeH

JendrossekV

RiehleA

von KurthyG

BergerJ

2003 Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 9 322 330

16. van BlitterswijkWJ

van der LuitAH

VeldmanRJ

VerheijM

BorstJ

2003 Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem J 369 199 211

17. FischerH

EllstromP

EkstromK

GustafssonL

GustafssonM

2007 Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4. Cell Microbiol

18. HannunYA

1994 The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269 3125 3128

19. HedlundM

DuanRD

NilssonA

SvenssonM

KarpmanD

2001 Fimbriae, transmembrane signaling, and cell activation. J Infect Dis 183 Suppl 1 S47 50

20. FrendeusB

WachtlerC

HedlundM

FischerH

SamuelssonP

2001 Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Mol Microbiol 40 37 51

21. HagbergL

HullR

HullS

McGheeJR

MichalekSM

1984 Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun 46 839 844

22. RagnarsdottirB

JonssonK

UrbanoA

Gronberg-HernandezJ

LutayN

2010 Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS One 5 e10734

23. WelchRA

BurlandV

PlunkettG3rd

RedfordP

RoeschP

2002 Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 99 17020 17024

24. GodalyG

BergstenG

HangL

FischerH

FrendeusB

2001 Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol 69 899 906

25. GodalyG

HangL

FrendeusB

SvanborgC

2000 Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice. J Immunol 165 5287 5294

26. KlemmP

RoosV

UlettGC

SvanborgC

SchembriMA

2006 Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect Immun 74 781 785

27. RoosV

SchembriMA

UlettGC

KlemmP

2006 Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae. Microbiology 152 1799 1806

28. KlemmP

HancockV

SchembriMA

2007 Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect Immun 75 3688 3695

29. ZdziarskiJ

SvanborgC

WulltB

HackerJ

DobrindtU

2008 Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect Immun 76 695 703

30. JohnsonJR

RobertsPL

StammWE

1987 P fimbriae and other virulence factors in Escherichia coli urosepsis: association with patients' characteristics. J Infect Dis 156 225 229

31. OttoG

SandbergT

MarklundBI

UllerydP

SvanborgC

1993 Virulence factors and pap genotype in Escherichia coli isolates from women with acute pyelonephritis, with or without bacteremia. Clin Infect Dis 17 448 456

32. BallouLR

LaulederkindSJ

RosloniecEF

RaghowR

1996 Ceramide signalling and the immune response. Biochim Biophys Acta 1301 273 287

33. SamuelssonP

HangL

WulltB

IrjalaH

SvanborgC

2004 Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun 72 3179 3186

34. RabelinkTJ

LuscherTF

2006 Endothelial nitric oxide synthase: host defense enzyme of the endothelium? Arterioscler Thromb Vasc Biol 26 267 271

35. Astarie-DequekerC

CarrenoS

CougouleC

Maridonneau-PariniI

2002 The protein tyrosine kinase Hck is located on lysosomal vesicles that are physically and functionally distinct from CD63-positive lysosomes in human macrophages. J Cell Sci 115 81 89

36. XueL

FirestoneGL

BjeldanesLF

2005 DIM stimulates IFNgamma gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways. Oncogene 24 2343 2353

37. MaoLM

TangQ

WangJQ

2007 Protein kinase C-regulated cAMP response element-binding protein phosphorylation in cultured rat striatal neurons. Brain Res Bull 72 302 308

38. ChriviaJC

KwokRP

LambN

HagiwaraM

MontminyMR

1993 Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365 855 859

39. LinR

GeninP

MamaneY

HiscottJ

2000 Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol Cell Biol 20 6342 6353

40. MayrB

MontminyM

2001 Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2 599 609

41. SanyalS

SandstromDJ

HoefferCA

RamaswamiM

2002 AP-1 functions upstream of CREB to control synaptic plasticity in Drosophila. Nature 416 870 874

42. ServantMJ

GrandvauxN

HiscottJ

2002 Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem Pharmacol 64 985 992

43. AuWC

MoorePA

LowtherW

JuangYT

PithaPM

1995 Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci U S A 92 11657 11661

44. FitzgeraldKA

RoweDC

BarnesBJ

CaffreyDR

VisintinA

2003 LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 198 1043 1055

45. HiscottJ

PithaP

GeninP

NguyenH

HeylbroeckC

1999 Triggering the interferon response: the role of IRF-3 transcription factor. J Interferon Cytokine Res 19 1 13

46. KawaiT

TakeuchiO

FujitaT

InoueJ

MuhlradtPF

2001 Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167 5887 5894

47. LeeJC

LaydonJT

McDonnellPC

GallagherTF

KumarS

1994 A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372 739 746

48. HanJ

RichterB

LiZ

KravchenkoV

UlevitchRJ

1995 Molecular cloning of human p38 MAP kinase. Biochim Biophys Acta 1265 224 227

49. SymonsA

BeinkeS

LeySC

2006 MAP kinase kinase kinases and innate immunity. Trends Immunol 27 40 48

50. McGettrickAF

BrintEK

Palsson-McDermottEM

RoweDC

GolenbockDT

2006 Trif-related adapter molecule is phosphorylated by PKC{epsilon} during Toll-like receptor 4 signaling. Proc Natl Acad Sci U S A 103 9196 9201

51. TaniguchiT

OgasawaraK

TakaokaA

TanakaN

2001 IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19 623 655

52. HondaK

TaniguchiT

2006 IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6 644 658

53. KiarashA

BoydB

LingwoodCA

1994 Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J Biol Chem 269 11138 11146

54. LingwoodCA

1993 Verotoxins and their glycolipid receptors. Adv Lipid Res 25 189 211

55. SvensonSB

HultbergH

KalleniusG

KorhonenTK

MollbyR

1983 P-fimbriae of pyelonephritogenic Escherichia coli: identification and chemical characterization of receptors. Infection 11 61 67

56. Ashkar AAMK

CoombesBK

GylesCL

MackenzieR

2008 FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog 4 e1000233

57. FrendeusB

GodalyG

HangL

KarpmanD

LundstedtAC

2000 Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med 192 881 890

58. LundstedtAC

LeijonhufvudI

RagnarsdottirB

KarpmanD

AnderssonB

2007 Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J Infect Dis 195 1227 1234

59. LundstedtAC

McCarthyS

GustafssonMC

GodalyG

JodalU

2007 A genetic basis of susceptibility to acute pyelonephritis. PLoS ONE 2 e825

60. RagnarsdottirB

SamuelssonM

GustafssonMC

LeijonhufvudI

KarpmanD

2007 Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J Infect Dis 196 475 484

61. AkahoshiM

NakashimaH

SadanagaA

MiyakeK

ObaraK

2008 Promoter polymorphisms in the IRF3 gene confer protection against systemic lupus erythematosus. Lupus 17 568 574

62. KuninC

1987 Urinary tract infections. Detection, prevention and management, 5th ed Baltimore Williams & Wilkins

63. FoxmanB

ManningSD

TallmanP

BauerR

ZhangL

2002 Uropathogenic Escherichia coli are more likely than commensal E. coli to be shared between heterosexual sex partners. Am J Epidemiol 156 1133 1140

64. KarpmanD

HåkanssonA

PerezM-TR

IsakssonC

CarlemalmE

1998 Apoptosis of renal cortical cells in the hemolytic uremic syndrome: in vivo and in vitro studies. Infect Immun 66 636 644

65. IwamuraT

YoneyamaM

YamaguchiK

SuharaW

MoriW

2001 Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6 375 388

66. ChuaSW

VijayakumarP

NissomPM

YamCY

WongVV

2006 A novel normalization method for effective removal of systematic variation in microarray data. Nucleic Acids Res 34 e38

67. DennisGJr

ShermanBT

HosackDA

YangJ

GaoW

2003 DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4 P3

68. KlemmP

JørgensenB

van DieI

de ReeH

BergmansH

1985 The fim genes responsible for the synthesis of type 1 fimbriae in Escherichia coli, cloning and genetic organization. Mol Gen Genet 199 410 414

69. van DieI

BergmansH

1984 Nucleotide sequence of the gene encoding the F72 fimbrial subunit of a uropathogenic Escherichia coli. Gene 32 83 90

70. DatsenkoKA

WannerBL

2000 One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97 6640 6645

71. BucE

VartanianMD

DarchaC

DechelotteP

PezetD

2005 Guanylyl cyclase C as a reliable immunohistochemical marker and its ligand Escherichia coli heat-stable enterotoxin as a potential protein-delivering vehicle for colorectal cancer cells. Eur J Cancer 41 1618 1627

72. MartinellJ

JodalU

Lidin-JansonG

1990 Pregnancies in women with and without renal scarring after urinary tract infections in childhood. Br Med J 300 840 844

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 9
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#